Clinical trial
Effectiveness of Adding Subcutaneous Long-Acting Detemir to Insulin Drip Therapy Compared With Standard Insulin Drip Therapy
NCT01186003
Study timeline
Study start (actual)2010-08-01Date precision: month
Registry last updated2021-12-07
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Diabetesunresolved
Interventions
DetemirDRUG
Sponsors & collaborators
University of Colorado, Denverlead sponsor
Novo Nordisk A/Scollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01186003 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.